List of articles with "Eli Lilly"

Lilly Acquires Verve

Lilly Acquires Verve

United States Indianapolis Cardiovascular Eli Lilly Verve Therapeutics
Donanemab Approved?

Donanemab Approved?

None Alzheimer's Eli Lilly Donanemab
Lilly and Verve Update

Lilly and Verve Update

United States Acquisition Indianapolis Eli Lilly Verve Therapeutics
Healthcare Forum

Healthcare Forum

Japan Tokyo Healthcare Innovation Eli Lilly Obesity Treatment
Growth of Sleep Apnea Market

Growth of Sleep Apnea Market

None Eli Lilly Apnimed Sleep Apnea Market
AI's Role in Healthcare

AI's Role in Healthcare

USA Vancouver AI Healthcare Avant Technologies Eli Lilly
Lilly Declares Q3 2025 Dividend

Lilly Declares Q3 2025 Dividend

None Dividend Shareholders Eli Lilly
Weekly Insulin Efsitora

Weekly Insulin Efsitora

United States Indianapolis Eli Lilly diabetes treatment Insulin Efsitora
Orforglipron's Phase 3 Results

Orforglipron's Phase 3 Results

United States Indianapolis Eli Lilly diabetes Orforglipron
Actos Class Action Ruling

Actos Class Action Ruling

USA San Francisco Eli Lilly Takeda Actos
Lilly Acquires Verve

Lilly Acquires Verve

United States Indianapolis Cardiovascular Disease Eli Lilly Verve Therapeutics
Lilly's Zepbound Access

Lilly's Zepbound Access

United States Indianapolis Zepbound tirzepatide Eli Lilly
Collaboration for Incretins

Collaboration for Incretins

Sweden Lund Eli Lilly Camurus FluidCrystal
Camurus and Lilly Collaborate

Camurus and Lilly Collaborate

Sweden Lund Eli Lilly Camurus FluidCrystal
Eli Lilly at GS Conference

Eli Lilly at GS Conference

United States Indianapolis Eli Lilly Health Care Goldman Sachs Conference
Lilly's Ovarian Cancer ADC

Lilly's Ovarian Cancer ADC

United States Indianapolis Eli Lilly Ovarian Cancer FRα
Grünenthal Acquires Cialis® Rights

Grünenthal Acquires Cialis® Rights

Germany Eli Lilly Grünenthal Aachen Cialis
Lilly at ADA Sessions

Lilly at ADA Sessions

USA Chicago Zepbound Eli Lilly Mounjaro
Lilly at ASCO 2025

Lilly at ASCO 2025

USA Chicago Cancer Research Eli Lilly ASCO 2025
Kisunla Alzheimer's Approval

Kisunla Alzheimer's Approval

Indianapolis Australia Alzheimer's Disease Eli Lilly Kisunla
Rznomics & Eli Lilly Partnership

Rznomics & Eli Lilly Partnership

South Korea Rznomics Seongnam Eli Lilly RNA Therapy
Lilly's $250M Deal with Purdue

Lilly's $250M Deal with Purdue

United States Indianapolis Purdue University Eli Lilly Pharmaceutical Innovation
April Health Recap

April Health Recap

Crunch Fitness Eli Lilly Novartis AG
Eli Lilly Executive Changes

Eli Lilly Executive Changes

United States Indianapolis Leadership Eli Lilly growth
Alchemab and Eli Lilly

Alchemab and Eli Lilly

Cambridge United Kingdom Eli Lilly Alchemab ATLX-1282
Lilly Q2 2025 Dividend

Lilly Q2 2025 Dividend

United States Dividend Indianapolis Eli Lilly NYSE:LLY
Lilly at Healthcare Conference

Lilly at Healthcare Conference

United States Indianapolis Healthcare Conference Eli Lilly Lucas Montarce
Eli Lilly's Q1 2025 Results

Eli Lilly's Q1 2025 Results

United States Indianapolis Zepbound Eli Lilly Mounjaro
Cancer Risks and Antipsychotics

Cancer Risks and Antipsychotics

USA Johnson & Johnson Alameda Eli Lilly Risperdal
OrderlyMeds vs. Eli Lilly

OrderlyMeds vs. Eli Lilly

United States Atlanta tirzepatide Eli Lilly OrderlyMeds
Platinum Ticket Investments

Platinum Ticket Investments

United States Cambridge biotechnology Eli Lilly Mission BioCapital
Lepodisiran's Breakthrough

Lepodisiran's Breakthrough

United States Indianapolis Heart Disease Eli Lilly Lepodisiran
LillyDirect Alzheimer's Care

LillyDirect Alzheimer's Care

United States Indianapolis Alzheimer's Eli Lilly LillyDirect
VERZENIO Market Insights

VERZENIO Market Insights

USA Las Vegas Eli Lilly Verzenio CDK4/6 inhibitors
Baricitinib's Impact on Hair Loss

Baricitinib's Impact on Hair Loss

USA Indianapolis Eli Lilly Alopecia Areata Baricitinib
EBGLYSS® Breakthrough

EBGLYSS® Breakthrough

United States Indianapolis Atopic Dermatitis Eli Lilly EBGLYSS
Maria José Rueda Joins ASA

Maria José Rueda Joins ASA

United States New York Eli Lilly American Skin Association Maria José Rueda
Lilly at Global Healthcare

Lilly at Global Healthcare

United States Indianapolis Healthcare Conference Eli Lilly Lucas Montarce
Lilly Manufacturing Expansion

Lilly Manufacturing Expansion

USA Manufacturing pharmaceuticals Washington D.C. Eli Lilly
Lilly's New Zepbound Doses

Lilly's New Zepbound Doses

USA Indianapolis Zepbound tirzepatide Eli Lilly
2025 Goodes Prize

2025 Goodes Prize

United States New York Eli Lilly Daniel Skovronsky Goodes Prize
Lilly at Health Care Conference

Lilly at Health Care Conference

United States Indianapolis biotechnology Eli Lilly Health Care
Omvoh Sustains Remission

Omvoh Sustains Remission

United States Indianapolis Crohn's Disease Eli Lilly Omvoh
Lilly Q4 2024 Results

Lilly Q4 2024 Results

United States Indianapolis Zepbound Eli Lilly Mounjaro
Omvoh® Approved for Crohn's

Omvoh® Approved for Crohn's

United States Indianapolis Crohn's Disease Eli Lilly Omvoh
Lilly's Revenue Guidance

Lilly's Revenue Guidance

United States Indianapolis revenue growth Eli Lilly Phrmaceuticals
Lilly's New Acquisition

Lilly's New Acquisition

United States Indianapolis Eli Lilly Scorpion Therapeutics STX-478
Thrive Global and Eli Lilly Partnership

Thrive Global and Eli Lilly Partnership

United States New York Thrive Global Eli Lilly Health Outcomes
Lilly at J.P. Morgan

Lilly at J.P. Morgan

United States Indianapolis Healthcare Conference J.P. Morgan Eli Lilly
Kisunla™ Approved in China

Kisunla™ Approved in China

China Nanjing Alzheimer’s Eli Lilly Kisunla™

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.